Abstract：
BACKGROUND: Medication adherence is essential for the achievement of therapeutic goals. Yet, the World Health Organization estimates that 50% of patients are nonadherent to medication and this has been associated with 125 billion euros and 200,000 deaths in Europe annually.
OBJECTIVE: This study aimed to unravel barriers and unmet training needs regarding medication adherence management across Europe.
METHODS: A cross-sectional study was conducted through an online survey. The final survey contained 19 close-ended questions.
METHODS: The survey content was informed by 140 global medication adherence experts from clinical, academic, governmental, and patient associations. The final survey targeted healthcare professionals (HCPs) across 39 European countries.
METHODS: Our measures were barriers and unmet training needs for the management of medication adherence across Europe.
RESULTS: In total, 2875 HCPs (pharmacists, 40%; physicians, 37%; nurses, 17%) from 37 countries participated. The largest barriers to adequate medication adherence management were lack of patient awareness (66%), lack of HCP time (44%), lack of electronic solutions (e.g., access to integrated databases and uniformity of data available) (42%), and lack of collaboration and communication between HCPs (41%). Almost all HCPs pointed out the need for educational training on medication adherence management.
CONCLUSIONS: These findings highlight the importance of addressing medication adherence barriers at different levels, from patient awareness to health system technology and to fostering collaboration between HCPs. To optimize patient and economic outcomes from prescribed medication, prerequisites include adequate HCP training as well as further development of digital solutions and shared health data infrastructures across Europe.
OBJECTIVE: This study aimed to unravel barriers and unmet training needs regarding medication adherence management across Europe.
METHODS: A cross-sectional study was conducted through an online survey. The final survey contained 19 close-ended questions.
METHODS: The survey content was informed by 140 global medication adherence experts from clinical, academic, governmental, and patient associations. The final survey targeted healthcare professionals (HCPs) across 39 European countries.
METHODS: Our measures were barriers and unmet training needs for the management of medication adherence across Europe.
RESULTS: In total, 2875 HCPs (pharmacists, 40%; physicians, 37%; nurses, 17%) from 37 countries participated. The largest barriers to adequate medication adherence management were lack of patient awareness (66%), lack of HCP time (44%), lack of electronic solutions (e.g., access to integrated databases and uniformity of data available) (42%), and lack of collaboration and communication between HCPs (41%). Almost all HCPs pointed out the need for educational training on medication adherence management.
CONCLUSIONS: These findings highlight the importance of addressing medication adherence barriers at different levels, from patient awareness to health system technology and to fostering collaboration between HCPs. To optimize patient and economic outcomes from prescribed medication, prerequisites include adequate HCP training as well as further development of digital solutions and shared health data infrastructures across Europe.
摘要：
背景：药物依从性对于实现治疗目标至关重要。然而，世界卫生组织估计，50％的患者不坚持药物治疗，这与欧洲每年1250亿欧元和200,000例死亡有关。
目的：本研究旨在消除整个欧洲药物依从性管理方面的障碍和未满足的培训需求。
方法：通过在线调查进行了一项横断面研究。最终调查包含19个封闭式问题。
方法：调查内容由来自临床、学术,政府,和患者协会。最终调查针对39个欧洲国家的医疗保健专业人员（HCP）。
方法：我们的措施是在整个欧洲的药物依从性管理方面的障碍和未满足的培训需求。
结果：总计，2875HCP(药剂师，40%；内科医生，37%；护士，17％）来自37个国家参加。充分的药物依从性管理的最大障碍是缺乏患者意识（66％）。缺乏HCP时间（44%），缺乏电子解决方案(例如，对集成数据库的访问和可用数据的一致性)(42%)，以及HCP之间缺乏合作和沟通(41%)。几乎所有的HCP都指出需要对药物依从性管理进行教育培训。
结论：这些发现强调了在不同层面解决药物依从性障碍的重要性。从患者意识到卫生系统技术，再到促进HCPs之间的合作。为了优化处方药的患者和经济结果，先决条件包括足够的HCP培训以及进一步开发整个欧洲的数字解决方案和共享健康数据基础设施。
目的：本研究旨在消除整个欧洲药物依从性管理方面的障碍和未满足的培训需求。
方法：通过在线调查进行了一项横断面研究。最终调查包含19个封闭式问题。
方法：调查内容由来自临床、学术,政府,和患者协会。最终调查针对39个欧洲国家的医疗保健专业人员（HCP）。
方法：我们的措施是在整个欧洲的药物依从性管理方面的障碍和未满足的培训需求。
结果：总计，2875HCP(药剂师，40%；内科医生，37%；护士，17％）来自37个国家参加。充分的药物依从性管理的最大障碍是缺乏患者意识（66％）。缺乏HCP时间（44%），缺乏电子解决方案(例如，对集成数据库的访问和可用数据的一致性)(42%)，以及HCP之间缺乏合作和沟通(41%)。几乎所有的HCP都指出需要对药物依从性管理进行教育培训。
结论：这些发现强调了在不同层面解决药物依从性障碍的重要性。从患者意识到卫生系统技术，再到促进HCPs之间的合作。为了优化处方药的患者和经济结果，先决条件包括足够的HCP培训以及进一步开发整个欧洲的数字解决方案和共享健康数据基础设施。
